Cargando…
Treatment of non-high-risk acute promyelocytic leukemia with realgar-indigo naturalis formula (RIF) and all-trans retinoid acid (ATRA): study protocol for a randomized controlled trial
BACKGROUND: Acute promyelocytic leukemia (APL) is a highly curable disease when treated with all-trans retinoid acid (ATRA) and arsenic trioxide (ATO). The combination of ATO and ATRA has become the standard therapeutic protocol for induction therapy in non-high-risk APL. An oral arsenic realgar-ind...
Autores principales: | Zhang, Xinxin, Liu, Li, Yao, Yazhou, Gong, Sha, Wang, Mengchang, Xi, Jieying, Chen, Limei, Wei, Suhua, Zhang, Huiyun, Zhao, Chenyang, Wang, Huaiyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941314/ https://www.ncbi.nlm.nih.gov/pubmed/31898521 http://dx.doi.org/10.1186/s13063-019-3983-2 |
Ejemplares similares
-
Oral Realgar-Indigo Naturalis Formula Plus Retinoic Acid for Acute Promyelocytic Leukemia
por: Lou, Yinjun, et al.
Publicado: (2021) -
Clinical Study on Prospective Efficacy of All-Trans Acid, Realgar-Indigo Naturalis Formula Combined with Chemotherapy as Maintenance Treatment of Acute Promyelocytic Leukemia
por: Xiang-Xin, Li, et al.
Publicado: (2014) -
Oral Realgar-Indigo Naturalis Formula Treatment for Acute Promyelocytic Leukemia in Children: A Randomized, Control Clinical Trial
por: Luo, Senlin, et al.
Publicado: (2022) -
Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial
por: Zhang, Xinxin, et al.
Publicado: (2018) -
Traditional mineral medicine realgar and Realgar-Indigo naturalis formula potentially exerted therapeutic effects by altering the gut microbiota
por: Luo, Lu, et al.
Publicado: (2023)